Detalhe da pesquisa
1.
Effects of GRIN2B , GRIA1 , and BDNF Polymorphisms on the Therapeutic Action of Ketamine and Esketamine in Treatment-Resistant Depression Patients: Secondary Analysis From a Randomized Clinical Trial.
Clin Neuropharmacol
; 45(6): 151-156, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36093918